Bio-Rad Laboratories (BIO-B) Gross Profit (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Gross Profit data on file, last reported at $309.4 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $309.4 million, up 1.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 1.16% YoY), and the FY2025 annual result was $1.3 billion, down 2.83% from the prior year.
• Gross Profit retreated to $309.4 million in Q1 2026 per BIO-B's latest filing, from $345.2 million in the prior quarter.
• Over five years, Gross Profit peaked at $402.6 million in Q1 2022 and troughed at $306.0 million in Q1 2025.
• A 5-year average of $354.3 million and a median of $355.1 million in 2024 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2024: Gross Profit fell 14.64% in 2022, then advanced 6.02% in 2024.
• A 5-year view of Gross Profit shows it stood at $397.1 million in 2022, then declined by 7.76% to $366.3 million in 2023, then retreated by 6.63% to $342.0 million in 2024, then advanced by 0.94% to $345.2 million in 2025, then retreated by 10.37% to $309.4 million in 2026.
• Business Quant data shows BIO-B's Gross Profit at $309.4 million in Q1 2026, $345.2 million in Q4 2025, and $343.4 million in Q3 2025.